Want to see ELTP full AI Analyst Report?
Elite Pharmaceuticals (ELTP) Income Statement
Elite Pharmaceuticals Income Statement
Last quarter (Q1 2027), Elite Pharmaceuticals's total revenue was $32.36M, an increase of 1.12% from the same quarter last year. In Q1, Elite Pharmaceuticals's net income was $5.91M. See Elite Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Jun 25 | Jun 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 148.87M | $ 84.04M | $ 56.63M | $ 34.16M | $ 32.26M | |
| $ 73.48M | $ 40.09M | $ 26.36M | $ 16.59M | $ 14.80M | |
| $ 23.52M | $ 20.49M | $ 15.57M | $ 12.92M | $ 9.72M | |
| Depreciation and Amortization | $ 2.02M | $ 2.12M | $ 1.47M | $ 1.34M | $ 1.43M |
| $ 51.98M | $ 2.84M | $ 2.52M | $ 6.44M | $ 6.51M | |
| $ 49.96M | $ 19.60M | $ 10.79M | $ 2.03B | $ 5.07M | |
| $ 6.85M | $ -19.65M | $ -10.33M | $ 309.87K | $ 2.09M | |
| $ 56.81M | $ -52.14K | $ 463.09K | $ 3.99M | $ 7.16M | |
| $ 44.87M | $ -4.31M | $ 20.11M | $ 4.41M | $ 8.90M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.04 | $ 0.00 | $ 0.02 | $ 4.35 | $ 0.01 |
| Diluted EPS | $ 0.03 | $ 0.00 | $ 0.02 | $ 4.35 | $ 0.01 |
| Weighted Average Shares Outstanding | 1.07B | 1.07B | 1.02B | 1.01B | 1.01B |
| Weighted Average Shares Outstanding (Diluted) | 1.14B | 1.07B | 1.02B | 1.01B | 1.01B |
Currency in USD